TY - JOUR
T1 - Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing
AU - Sharma, S. K.
AU - Kumpawat, Saket
AU - Goel, Ashish
AU - Banga, Amit
AU - Ramakrishnan, Lakshmi
AU - Chaturvedi, Pradeep
PY - 2007/1
Y1 - 2007/1
N2 - Objective: To assess the profile of metabolic abnormalities in subjects with obstructive sleep apnea (OSA). Patients and methods: In a case-control study conducted in two years, from April 2003 to March 2005, data obtained from polysomnography study, lipid profile, fasting blood sugar, serum insulin, insulin resistance, leptin and adiponectin levels, were compared between the various groups. Included in the study were OSA subjects from a sleep laboratory and matched controls from the community. Those with recent myocardial infarction, upper airway surgery, class III/IV heart failure, pregnancy, acromegaly, chronic renal failure, or who were on treatment for hyperthyroidism, on systemic steroid treatment, or on hormonal replacement therapy, were excluded from the study. Results: Forty apneic obese subjects (AHI = 32.19, range 13-52.75) were compared with 40 non-apneic obese controls (AHI = 1.3, range 0-2.45) and 40 normal weight control subjects (AHI = 0.7, range 0-1). No significant difference was noted in levels of fasting blood sugar, insulin resistance (obese apneics 61.9, obese controls 47.8, non-obese controls 19.1), leptin (obese apneics 10.65 μg/L, obese controls 8.52 μg/L, non-obese controls 2.83 μg/L) or adiponectin (obese apneics 4959.3 ng/ml, obese controls 5706 ng/ml, non-obese controls 7412 ng/ml) in the OSA group compared to obese controls. Conclusions: OSA has no independent association with lipid abnormalities, insulin resistance, serum leptin and adiponectin levels. In multivariate analysis, obesity was the major determinant of metabolic abnormalities in this cohort.
AB - Objective: To assess the profile of metabolic abnormalities in subjects with obstructive sleep apnea (OSA). Patients and methods: In a case-control study conducted in two years, from April 2003 to March 2005, data obtained from polysomnography study, lipid profile, fasting blood sugar, serum insulin, insulin resistance, leptin and adiponectin levels, were compared between the various groups. Included in the study were OSA subjects from a sleep laboratory and matched controls from the community. Those with recent myocardial infarction, upper airway surgery, class III/IV heart failure, pregnancy, acromegaly, chronic renal failure, or who were on treatment for hyperthyroidism, on systemic steroid treatment, or on hormonal replacement therapy, were excluded from the study. Results: Forty apneic obese subjects (AHI = 32.19, range 13-52.75) were compared with 40 non-apneic obese controls (AHI = 1.3, range 0-2.45) and 40 normal weight control subjects (AHI = 0.7, range 0-1). No significant difference was noted in levels of fasting blood sugar, insulin resistance (obese apneics 61.9, obese controls 47.8, non-obese controls 19.1), leptin (obese apneics 10.65 μg/L, obese controls 8.52 μg/L, non-obese controls 2.83 μg/L) or adiponectin (obese apneics 4959.3 ng/ml, obese controls 5706 ng/ml, non-obese controls 7412 ng/ml) in the OSA group compared to obese controls. Conclusions: OSA has no independent association with lipid abnormalities, insulin resistance, serum leptin and adiponectin levels. In multivariate analysis, obesity was the major determinant of metabolic abnormalities in this cohort.
KW - Insulin resistance
KW - Lipid profile
KW - Metabolic syndrome
KW - Obesity
KW - Obstructive sleep apnea
KW - Polysomnography
KW - Sleep-disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=33845989096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845989096&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2006.06.014
DO - 10.1016/j.sleep.2006.06.014
M3 - Article
C2 - 17157064
AN - SCOPUS:33845989096
SN - 1389-9457
VL - 8
SP - 12
EP - 17
JO - Sleep Medicine
JF - Sleep Medicine
IS - 1
ER -